Creative regulatory practices to develop stem-cell technology: the way forward for Malaysia

Document Type

Article

Publication Date

2-1-2022

Abstract

Malaysia aspires to develop regenerative medicine through stem-cell technology. It needs a regulatory system that could facilitate development and prevent unethical practices. A comparative legal analysis on the regulation of stem-cell technology, with a focus on stem-cell research in Malaysia and selected Commonwealth countries that are experienced in regulating this complex technology, demonstrates that the selected Commonwealth countries have adopted a hybrid of different regulatory mechanisms. This paper argues that Malaysia should consider adopting a similar approach to equip relevant authorities with different regulatory mechanisms that are able to promote innovation in stem-cell research activities and cultivate a successful and profitable regenerative medicine industry in the future. Such a strategic action can produce an optimal regulatory outcome and help Malaysia to realize its aspiration.

Keywords

Commonwealth, Ethics, Innovation, Malaysia, Regenerative medicine, Regulation, Stem cells

Divisions

fac_law

Publication Title

Regenerative Medicine

Volume

17

Issue

2

Publisher

Future Medicine Ltd

Publisher Location

UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3 1QB, ENGLAND

This document is currently not available here.

Share

COinS